Scientists from Nanyang Technological University (NTU) and
the Singapore Eye Research Institute (SERI) have jointly developed a new
nanomedicine that will allow glaucoma patients to do away with daily eye drops.
Glaucoma is a disease which could lead to blindness. This
new sustained-release drug therapy can provide months of relief to glaucoma
patients with a single application, compared to just hours with today’s
conventional eye drops.